Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia With Losing Major Molecular Response as a Definition for Molecular Relapse: A Systematic Review and Meta-Analysis

Схожие документы

• Interferon-α may help prevent molecular relapse of chronic myeloid leukemia after the discontinuation of tyrosine kinase inhibitors
  по: Jun, Kong, и др.
  Опубликовано: (2021)
• P677: THE FACTORS OF LATE MOLECULAR RELAPSES AFTER TYROSINE KINASE INHIBITORS DISCONTINUATION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
  по: Petrova, Anna, и др.
  Опубликовано: (2023)
• Patient-Initiated Discontinuation of Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia
  по: Langabeer, Stephen E., и др.
  Опубликовано: (2020)
• Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when and for whom?
  по: Atallah, Ehab, и др.
  Опубликовано: (2020)
• The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era
  по: Renault, Ilana Zalcberg, и др.
  Опубликовано: (2011)